Danish drugmaker Novo Nordisk said the first-of-its kind oral pill will offer 1.5 and 4 milligram doses at $149 per month for self-paying patients.

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

The U.S. Food and Drug Administration approved the Wegovy pill in late December 2025 for adults who are obese or overweight and have related health problems. The pill is designed to be used along with a lower-calorie diet and more physical activity to help people lose weight and keep it off.

The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.

(Bloomberg) — As far as drug companies go, abortion-pill maker Danco Laboratories is all but anonymous. It has fewer than 20 employees, uses a P.O. Box instead of listing a headquarters address and isn’t listed on any public exchanges. Now its sole ...

Abortion ban clashes with federal drug rules, company says Judge weighing dismissal seemed leery of both sides Part of nationwide battle over access to abortion pill (Reuters) - Lawyers for abortion pill maker GenBioPro Inc on Tuesday urged a West Virginia ...

A generic-mifepristone maker sued the U.S. Food and Drug Administration to protect access to the medical abortion pill amid a welter of litigation stretching from Texas to Washington. The lawsuit by GenBioPro Inc., filed Wednesday in federal court in ...

The first GLP-1 oral pill is now available at pharmacies nationwide. The Wegovy pill was approved by the Food and Drug Administration on December 22. Having an oral version of the medication, which had only been available as an injectable until now,